What question did this study set out to answer?

This research aims to clarify the clinical features, molecular landscape, and treatment outcomes in patients with Erdheim-Chester disease associated with myeloid neoplasms.

April 10, 2026HemaSphereOpen Access

Erdheim‐Chester disease associated with myeloid neoplasm: Clinical features, molecular landscape, and treatment outcomes

View Full Paper

Ask AI

Bookmark

Authors

APA. Le PogamSorbonne Université MPMatthias Papo PHPierre HirschInserm

Discussion

Member takes

Implication

Patients with Erdheim-Chester Disease and Myeloid Neoplasm show varied clinical features and response rates to treatments, indicating treatment strategies.

Key Points

This research aims to clarify the clinical features, molecular landscape, and treatment outcomes in patients with Erdheim-Chester disease associated with myeloid neoplasms.
Analyzed 67 patients with ECD associated with MN from a French national cohort.
Compared clinical outcomes to 348 patients with ECD without MN.
Assessed treatment response to kinase inhibitors and pegylated-interferon α.
Evaluated progression of myeloid neoplasms and rates of leukemic transformation.
Patients with ECD-MN were older and exhibited broader organ involvement compared to those without MN.
KI therapy resulted in higher response rates (96%) compared to Peg-IFN (58%).
Myeloid neoplasm progression at 6 months was similar in both treatment groups (25%).
Median overall survival was shorter in ECD-MN patients (76 months) compared to those without MN (163 months).

Cite This Study

Pogam et al. (2026) studied this question.

synapsesocial.com/papers/69d8967d6c1944d70ce07fdb https://doi.org/10.1002/hem3.70349

View Full Paper

Ask AI

Bookmark

Implication

Patients with Erdheim-Chester Disease and Myeloid Neoplasm show varied clinical features and response rates to treatments, indicating treatment strategies.

Erdheim‐Chester disease associated with myeloid neoplasm: Clinical features, molecular landscape, and treatment outcomes

Discussion

Member takes

Implication

Key Points

Cite This Study

Erdheim‐Chester disease associated with myeloid neoplasm: Clinical features, molecular landscape, and treatment outcomes

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider